AGENDA

(For Spring 2020 Oncology Meeting)

Infectious Disease Final Agenda To Be Announced June 1, 2020.

TUESDAY, MARCH 31

8:30am // OPENING REMARKS

8:40am // TALK - RALPH PARCHMENT, NCI, MANAGING DIRECTOR, DCTD PROGRAM IN PHARMCODYNAMIC BIOMARKERS

​9:10am // KEYNOTE TALK - BRIAN LELAND-JONES (FRM DIRECTOR OF THE EMORY AND MCGILL CANCER CENTERS)

                   Transformation in Cancer Diagnosis and Treatment 2020

09:40am // Corporate Presentation - OTraces

10:00am // Corporate Presentation - Travera

10:20am // Corporate Presentation - Ovensa

10:40am // Corporate Presentation - Kineta

11:00am // Corporate Presentation - Flow Pharmaceuticals

11:20am // Corporate Presentation - Modra Pharmaceuticals

11:40am // Corporate Presentation - SciTech

12:00pm // Corporate Presentation - Onconova Therapeutics
12:20 pm //  Corporate Presentation - Ehmet Health 

12:40 pm //  Corporate Presentation - Telexos
1:00pm // CFIUS TALK
                   Robbin Goodman, Director of Business Affairs, George H. W. Bush Foundation for U.S.-China Relation

1:15pm // Corporation Presentation - Katena Oncology

1:35pm // Corporation Presentation - Canget BioTekpharma
1:55pm // Corporation Presentation - Creatv Microtech

2:15pm // Corporation Presentation - Jubilant Life Sciences

2:35pm // Corporation Presentation - LifeBridge 1000

2:55pm // Corporation Presentation - GenEndeavor

3:15pm // Corporation Presentation - ENB Therapeutics

3:35pm // Corporation Presentation - Lightpoint Medical

3:55pm // Corporation Presentation - TomoWave Laboratories

4:15pm // BREAK 

4:30pm // Corporation Presentation - SynDevRx

4:50pm // Corporation Presentation - Ziteo Medical

5:10pm // Corporation Presentation - OncoSynergy

5:30pm // Corporation Presentation - Vitanova Biomedical

5:50pm // SPEAKER - Fred Nazem, Former CEO/Chairman Oxford Health, GP of 7 Venture Funds

                    EVOLUTION OF LIFE SCIENCE VENTURE CAPITAL FROM 1970-2020

6:15pm // Corporation Presentation - Rejuvenan

6:35pm // CLOSING REMARKS

WEDNESDAY, APRIL 1

8:00am // OPENING REMARKS 

8:10am // PANEL - HOW COVID-19 WILL INFLUENCE ONCOLOGY CLINICAL TRIALS

                   Moderator: Roy Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology) and Professor of Pharmacology; Chief of Medical Oncology,

                                         Yale Cancer Center and Smilow Cancer Hospital; Associate Cancer Center Director for Translational Research, Yale Cancer Center
                   Panelist:      Mario Sznol, MD (panel role: oncologist, Professor of Medicine (Medical Oncology); Co-Leader, Cancer Immunology, Yale Cancer

                                         Center;  Co-Director, Yale SPORE in Skin Cancer

                                         Brinda Emu, MD (panel role: virologist), Assistant Professor of Medicine (Infectious Diseases), Yale School of Medicine

                                         Paolo A. Ascierto, MD  (panel role: oncologist), Vice-Director of the Unit of Melanoma, Cancer Immunotherapy and Innovative

                                                                                    Therapy Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Tumor Institute

                                                                                    Fondazione G. Pascale, Naples, Italy

8:40am // KEYNOTE - COVID: OUR LIFE SCIENCES SPUTNIK MOMENT

                   Dr. Ronald DePinho, Former President, MD Anderson Cancer Center

9:10am // Corporate Presentation - Impact Therapeutics

9:30am // Corporate Presentation - Summit Biomedical Imaging

9:50am // Corporate Presentation - Incysus

10:10am // Corporate Presentation - Imagion

10:30am // Corporate Presentation - Qrono

10:50am // Corporate Presentation - LeadInvent Pharma

11:10am // Corporate Presentation - Diverse Biotech

11:30am // Corporate Presentation - NeoTherma

11:50am // Corporate Presentation - Oleander Medical Technologies

12:10am // Corporate Presentation - Aro Biotherapeutics

12:30pm // LUNCH TALK - APPLYING FINANCIAL ENGINEERING TO CANCER
                     Dr. Andrew Lo, Director, Laboratory for Financial Engineering, MIT

1:00pm // Corporate Presentation - AHEAD Medicine

1:20pm // Corporate Presentation - Promaxo

1:40pm // Corporate Presentation - Cybrexa Therapeutics

2:00pm // Corporate Presentation - iMedis

2:20pm // Corporate Presentation - My Personal Therapeutics

2:40pm // Corporate Presentation - Glysantis

3:00pm // Corporate Presentation - ImmuneCyte Life Sciences

3:20pm // KEYNOTE - NORMAL AND NEOPLASTIC STEM CELLS

                   Dr. Irving Weissman, Director, Institute for Stem Cell Biology & Regenerative Medicine AND Stanford Ludwig Center for Cancer Stem Cell                                             Research and Medicine

 4:00pm // SPECIAL TALK - HOW PRIVATE SECTOR FUNDS CAN ADD LIQUIDITY, ENABLE, AND SHIFT RISK IN GOVERNMENTAL HEALTHCARE

                                                    PURCHASES DURING THE COVID CRISIS

                   Doug Monticciolo, CEO and Founder, Brevet Capital (A Global Leader in Impact Investment) 

4:10pm // Corporate Presentation - GlycoMantra

4:30pm // Corporate Presentation - LeadInvent Pharma

4:50pm // Corporate Presentation - Decoy Biosystems
5:10pm // Corporate Presentation - Geneius Biotechnology
5:30pm // Corporate Presentation - SageMedic

5:50pm // Corporate Presentation - Apricity

6:10pm // Corporate Presentation - Tvardi

6:30pm // CLOSING REMARKS